Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 50, 2013, Pages

  Wang, Yanyan ^a   Huang, Gonghua ^a   Zeng, Hu ^a   Yang, Kai ^a   Lamb, Richard F ^b   Chi, Hongbo ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; INTERLEUKIN 12P35; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MYC PROTEIN; PROTEIN; RHEB PROTEIN; TAMOXIFEN; TUBEROUS SCLEROSIS 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL MATURATION; CELL METABOLISM; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVITY; GLYCOLYSIS; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LIPOGENESIS; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

EID: 84890288918     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308905110     Document Type: Article

References (62)

1. Wang R, Green DR (2012) Metabolic checkpoints in activated T cells. Nat Immunol 13(10):907-915.
2. MacIver NJ, Michalek RD, Rathmell JC (2013) Metabolic regulation of T lymphocytes. Annu Rev Immunol 31:259-283.
3. Pearce EL, Pearce EJ (2013) Metabolic pathways in immune cell activation and quiescence. Immunity 38(4):633-643.
4. Wang R, et al. (2011) The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35(6):871-882.
5. Shi LZ, et al. (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208(7):1367-1376.
6. + T cell subsets. J Immunol 186(6):3299-3303.
7. Bensinger SJ, et al. (2008) LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134(1):97-111.
8. Kidani Y, et al. (2013) Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat Immunol 14(5):489-499.
9. Pearce EL, et al. (2009) Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460(7251):103-107
10. + T cell memory development. Immunity 36(1):68-78.
11. Everts B, et al. (2012) Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 120(7):1422-1431.
12. Krawczyk CM, et al. (2010) Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115(23):4742-4749.
13. Masters SL, et al. (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol 11(10):897-904.
14. Tannahill GM, et al. (2013) Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496(7444):238-242.
15. Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274-293.
16. Düvel K, et al. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39(2):171-183.
17. Chi H (2012) Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol 12(5):325-338.
18. Powell JD, Pollizzi KN, Heikamp EB, Horton MR (2012) Regulation of immune responses by mTOR. Annu Rev Immunol 30:39-68.
19. Thomson AW, Turnquist HR, Raimondi G (2009) Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9(5):324-337.
20. Weichhart T, et al. (2008) The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29(4):565-577.
21. Ohtani M, et al. (2008) Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 112(3):635-643.
22. Schmitz F, et al. (2008) Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur J Immunol 38(11):2981-2992.
23. Haidinger M, et al. (2010) A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation. J Immunol 185(7):3919-3931.
24. + dendritic cells regulates intestinal homeostasis by promoting IL-10 production. J Immunol 188(10):4736-4740.
25. Cao W, et al. (2008) Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol 9(10):1157-1164.
26. Amiel E, et al. (2012) Inhibition of mechanistic target of rapamycin promotes dendritic cell activation and enhances therapeutic autologous vaccination in mice. J Immunol 189(5):2151-2158.
27. Sathaliyawala T, et al. (2010) Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. Immunity 33(4):597-606.
28. + T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS. Blood 115(23):4758-4769.
29. Rosborough BR, et al. (2013) Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction. Blood 121(18):3619-3630.
30. Choo AY, Yoon SO, Kim SG, Roux PP, Blenis J (2008) Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci USA 105(45):17414-17419.
31. Sarbassov DD, et al. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22(2):159-168.
32. Delgoffe GM, et al. (2011) The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 12(4):295-303.
33. Liu K, et al. (2009) In vivo analysis of dendritic cell development and homeostasis. Science 324(5925):392-397.
34. Liu K, Nussenzweig MC (2010) Origin and development of dendritic cells. Immunol Rev 234(1):45-54.
35. Merad M, Sathe P, Helft J, Miller J, Mortha A (2013) The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31:563-604.
36. Chen C, et al. (2008) TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 205(10):2397-2408.
37. Gan B, et al. (2008) mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc Natl Acad Sci USA 105(49):19384-19389.
38. Fogg DK, et al. (2006) A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311(5757):83-87.
39. Varol C, et al. (2007) Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med 204(1):171-180.
40. Waskow C, et al. (2008) The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol 9(6):676-683.
41. Yang K, Neale G, Green DR, He W, Chi H (2011) The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat Immunol 12(9):888-897.
42. Chen M, Wang J (2010) Programmed cell death of dendritic cells in immune regulation. Immunol Rev 236(1):11-27.
43. Joffre O, Nolte MA, Spörri R, Reis e Sousa C (2009) Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 227(1):234-247.
44. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28:445-489.
45. Porstmann T, et al. (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8(3):224-236.
46. Yecies JL, et al. (2011) Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 14(1):21-32.
47. Kenerson HL, Yeh MM, Yeung RS (2011) Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation. PLoS One 6(3):e18075.
48. Huang J, Dibble CC, Matsuzaki M, Manning BD (2008) The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol 28(12):4104-4115.
49. O' Brien TF, et al. (2011) Regulation of T-cell survival and mitochondrial homeostasis by TSC1. Eur J Immunol 41(11):3361-3370.
50. + T cell survival and homeostasis in mice. PLoS One 7(2):e30592.
51. Gwinn DM, et al. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30(2):214-226.
52. Pan H, et al. (2013) Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA. J Immunol 191(2):699-707.
53. Shen WH, et al. (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128(1):157-170.
54. Zou J, et al. (2011) Rheb1 is required for mTORC1 and myelination in postnatal brain development. Dev Cell 20(1):97-108.
55. Gan B, et al. (2010) Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 468(7324):701-704.
56. Gurumurthy S, et al. (2010) The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 468(7324):659-663.
57. Nakada D, Saunders TL, Morrison SJ (2010) Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468(7324):653-658.
58. Lee JY, et al. (2010) mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion. Cell Stem Cell 7(5):593-605.
59. Pan H, O'Brien TF, Zhang P, Zhong XP (2012) The role of tuberous sclerosis complex 1 in regulating innate immunity. J Immunol 188(8):3658-3666.
60. Huang G, Wang Y, Shi LZ, Kanneganti TD, Chi H (2011) Signaling by the phosphatase MKP-1 in dendritic cells imprints distinct effector and regulatory T cell fates. Immunity 35(1):45-58.
61. Wang Y, et al. (2012) Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function. Proc Natl Acad Sci USA 109(6):E343-E352.
62. Huang G, et al. (2012) Signaling via the kinase p38α programs dendritic cells to drive TH17 differentiation and autoimmune inflammation. Nat Immunol 13(2):152-161.